Q3 2025 · 13F-HR
BROADWOOD CAPITAL INCholdings as filed
Filed 2025-11-14 · accession 0000919574-25-006810
$1.66B
Reported value
12
Positions
2025-09-30
Period end
The Brief · BROADWOOD CAPITAL INC · Q3 2025
AI · grounded in 13F
Broadwood Capital Inc established a new position in Monster Beverage Corp New MNST valued at $555.3M. The fund also initiated stakes in Axon Enterprise Inc AXON for $497.7M and Staar Surgical Co STAA for $363.3M. Additional new positions include iShares TR IWM, Lineage Cell Therapeutics In LCTX, and Insight Molecular Dia Inc IMDX.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 61174X109 | MNST | MONSTER BEVERAGE CORP NEW | $555.3M | 33.4% | 8,250,428 | Common | SOLE |
| 05464C101 | AXON | AXON ENTERPRISE INC | $497.7M | 30.0% | 693,504 | Common | SOLE |
| 852312305 | STAA | STAAR SURGICAL CO | $363.3M | 21.9% | 13,519,491 | Common | SOLE |
| 464287655 | IWM | ISHARES TR | $114.9M | 6.92% | 474,920 | Common | SOLE |
| 53566P109 | LCTX | LINEAGE CELL THERAPEUTICS IN | $83.8M | 5.04% | 49,560,992 | Common | SOLE |
| 68235C206 | IMDX | INSIGHT MOLECULAR DIA INC | $37.9M | 2.28% | 11,410,100 | Common | SOLE |
| 910047109 | UAL | UNITED AIRLS HLDGS INC | $4.3M | 0.26% | 150,000 | CALL | SOLE |
| 410345102 | HN9 | HANESBRANDS INC | $1.8M | 0.11% | 1,127,500 | CALL | SOLE |
| 844741108 | LUV | SOUTHWEST AIRLS CO | $713,700 | 0.04% | 183,000 | CALL | SOLE |
| 02376R102 | AAL | AMERICAN AIRLS GROUP INC | $709,300 | 0.04% | 820,000 | CALL | SOLE |
| 247361702 | DAL | DELTA AIR LINES INC DEL | $703,500 | 0.04% | 52,500 | CALL | SOLE |
| 81751A108 | SER | SERINA THERAPEUTICS INC | $445,925 | 0.03% | 83,195 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.